ECSP088603A - Nuevas n-(fluor-pirazinil)-fenilsulfonamidas como moduladores del receptor de quimioquina ccr4 - Google Patents
Nuevas n-(fluor-pirazinil)-fenilsulfonamidas como moduladores del receptor de quimioquina ccr4Info
- Publication number
- ECSP088603A ECSP088603A EC2008008603A ECSP088603A ECSP088603A EC SP088603 A ECSP088603 A EC SP088603A EC 2008008603 A EC2008008603 A EC 2008008603A EC SP088603 A ECSP088603 A EC SP088603A EC SP088603 A ECSP088603 A EC SP088603A
- Authority
- EC
- Ecuador
- Prior art keywords
- pirazinil
- penylsulphonamides
- chemioquine
- ccr4
- fluor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D241/20—Nitrogen atoms
- C07D241/22—Benzenesulfonamido pyrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Transplantation (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
La invención proporciona N-(flúor-pirazinil)-fenilsulfonamidas de fórmula (I), donde R1 -R5 son tal como se definen en la especificación; procesos y productos intermedios utilizados en su preparación, composiciones farmacéuticas que los contienen y su uso en terapia.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0502733 | 2005-12-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
ECSP088603A true ECSP088603A (es) | 2008-08-29 |
Family
ID=38163190
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EC2008008603A ECSP088603A (es) | 2005-12-12 | 2008-07-04 | Nuevas n-(fluor-pirazinil)-fenilsulfonamidas como moduladores del receptor de quimioquina ccr4 |
Country Status (21)
Country | Link |
---|---|
US (2) | US20080293742A1 (es) |
EP (1) | EP1968951B1 (es) |
JP (1) | JP2009519332A (es) |
KR (1) | KR20080091139A (es) |
CN (1) | CN101370793B (es) |
AR (1) | AR058319A1 (es) |
AT (1) | ATE513819T1 (es) |
AU (1) | AU2006325573A1 (es) |
BR (1) | BRPI0619602A2 (es) |
CA (1) | CA2631342A1 (es) |
CL (1) | CL2006003449A1 (es) |
EC (1) | ECSP088603A (es) |
ES (1) | ES2366807T3 (es) |
HK (1) | HK1121760A1 (es) |
IL (1) | IL191761A0 (es) |
NO (1) | NO20083070L (es) |
RU (1) | RU2008122401A (es) |
TW (1) | TW200730512A (es) |
UY (1) | UY29999A1 (es) |
WO (1) | WO2007069978A1 (es) |
ZA (1) | ZA200804921B (es) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI328007B (en) * | 2002-01-16 | 2010-08-01 | Astrazeneca Ab | Novel compounds |
KR101687144B1 (ko) * | 2009-04-22 | 2016-12-15 | 액시킨 파마수티컬스 인코포레이티드 | 2,5-이치환된 아릴설폰아마이드 ccr3 길항제 |
EP4215209A1 (en) * | 2013-09-02 | 2023-07-26 | The University of Melbourne | A method of treatment |
CN104447756A (zh) * | 2014-11-10 | 2015-03-25 | 常州大学 | 一种五氟磺草胺中间体的制备方法 |
CN104402890A (zh) * | 2014-11-10 | 2015-03-11 | 常州大学 | 一种制备五氟磺草胺的方法 |
JP2021502345A (ja) | 2017-11-06 | 2021-01-28 | ラプト・セラピューティクス・インコーポレイテッド | 抗がん剤 |
CN110028501B (zh) | 2018-01-12 | 2022-02-22 | 迈德欣国际有限公司 | 化合物及其制备方法和用途 |
CN108929279A (zh) * | 2018-07-27 | 2018-12-04 | 同济大学 | 一种含氟氨基吡嗪类化合物及其制备方法与应用 |
CN113893220A (zh) * | 2020-07-07 | 2022-01-07 | 迈德欣国际有限公司 | 鼻粘膜给药剂型和其应用 |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB928151A (en) * | 1959-07-14 | 1963-06-06 | Farmaceutici Italia | Pyrazine derivatives |
US5962490A (en) * | 1987-09-25 | 1999-10-05 | Texas Biotechnology Corporation | Thienyl-, furyl- and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin |
GB9624482D0 (en) | 1995-12-18 | 1997-01-15 | Zeneca Phaema S A | Chemical compounds |
HUP9901155A3 (en) | 1996-02-13 | 2003-04-28 | Astrazeneca Ab | Quinazoline derivatives as vegf inhibitors |
KR100489174B1 (ko) | 1996-03-05 | 2005-09-30 | 제네카-파마 소시에떼아노님 | 4-아닐리노퀴나졸린유도체 |
GB9718972D0 (en) | 1996-09-25 | 1997-11-12 | Zeneca Ltd | Chemical compounds |
GB9714249D0 (en) | 1997-07-08 | 1997-09-10 | Angiogene Pharm Ltd | Vascular damaging agents |
US6638937B2 (en) * | 1998-07-06 | 2003-10-28 | Bristol-Myers Squibb Co. | Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
GB9900334D0 (en) | 1999-01-07 | 1999-02-24 | Angiogene Pharm Ltd | Tricylic vascular damaging agents |
GB9900752D0 (en) | 1999-01-15 | 1999-03-03 | Angiogene Pharm Ltd | Benzimidazole vascular damaging agents |
KR20030013433A (ko) | 2000-05-31 | 2003-02-14 | 아스트라제네카 아베 | 혈관 손상 활성을 가진 인돌 유도체 |
EP1301497A1 (en) | 2000-07-07 | 2003-04-16 | Angiogene Pharmaceuticals Limited | Colchinol derivatives as vascular damaging agents |
HUP0301742A3 (en) | 2000-07-07 | 2005-08-29 | Angiogene Pharm Ltd | Colchinol derivatives as angiogenesis inhibitors, process for producing them, pharmaceutical compositions containing them and their use |
SE0102439D0 (sv) * | 2001-07-05 | 2001-07-05 | Astrazeneca Ab | New compounds |
ATE312096T1 (de) * | 2001-12-18 | 2005-12-15 | Neue verbindungen | |
TWI328007B (en) * | 2002-01-16 | 2010-08-01 | Astrazeneca Ab | Novel compounds |
SE0301650D0 (sv) * | 2003-06-04 | 2003-06-04 | Astrazeneca Ab | Novel compounds |
SE0301653D0 (sv) * | 2003-06-05 | 2003-06-05 | Astrazeneca Ab | Novel compounds |
SE0301654D0 (sv) * | 2003-06-05 | 2003-06-05 | Astrazeneca Ab | Novel compounds |
SE0302304D0 (sv) * | 2003-08-27 | 2003-08-27 | Astrazeneca Ab | Novel compounds |
-
2006
- 2006-11-29 TW TW095144144A patent/TW200730512A/zh unknown
- 2006-12-11 CN CN2006800527066A patent/CN101370793B/zh not_active Expired - Fee Related
- 2006-12-11 UY UY29999A patent/UY29999A1/es not_active Application Discontinuation
- 2006-12-11 AU AU2006325573A patent/AU2006325573A1/en not_active Abandoned
- 2006-12-11 BR BRPI0619602-0A patent/BRPI0619602A2/pt not_active Application Discontinuation
- 2006-12-11 US US12/096,513 patent/US20080293742A1/en not_active Abandoned
- 2006-12-11 RU RU2008122401/04A patent/RU2008122401A/ru not_active Application Discontinuation
- 2006-12-11 KR KR1020087016880A patent/KR20080091139A/ko not_active Application Discontinuation
- 2006-12-11 EP EP06835834A patent/EP1968951B1/en active Active
- 2006-12-11 AT AT06835834T patent/ATE513819T1/de not_active IP Right Cessation
- 2006-12-11 ES ES06835834T patent/ES2366807T3/es active Active
- 2006-12-11 WO PCT/SE2006/001409 patent/WO2007069978A1/en active Application Filing
- 2006-12-11 CL CL200603449A patent/CL2006003449A1/es unknown
- 2006-12-11 JP JP2008545537A patent/JP2009519332A/ja active Pending
- 2006-12-11 CA CA002631342A patent/CA2631342A1/en not_active Abandoned
- 2006-12-12 AR ARP060105466A patent/AR058319A1/es unknown
-
2008
- 2008-05-27 IL IL191761A patent/IL191761A0/en unknown
- 2008-06-05 ZA ZA200804921A patent/ZA200804921B/xx unknown
- 2008-07-04 EC EC2008008603A patent/ECSP088603A/es unknown
- 2008-07-08 NO NO20083070A patent/NO20083070L/no not_active Application Discontinuation
-
2009
- 2009-02-24 HK HK09101721.5A patent/HK1121760A1/xx not_active IP Right Cessation
- 2009-12-08 US US12/633,548 patent/US20100144759A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CN101370793A (zh) | 2009-02-18 |
EP1968951A1 (en) | 2008-09-17 |
UY29999A1 (es) | 2007-07-31 |
AR058319A1 (es) | 2008-01-30 |
ZA200804921B (en) | 2009-09-30 |
ES2366807T3 (es) | 2011-10-25 |
JP2009519332A (ja) | 2009-05-14 |
BRPI0619602A2 (pt) | 2011-10-11 |
NO20083070L (no) | 2008-08-28 |
ATE513819T1 (de) | 2011-07-15 |
RU2008122401A (ru) | 2010-01-20 |
US20080293742A1 (en) | 2008-11-27 |
US20100144759A1 (en) | 2010-06-10 |
TW200730512A (en) | 2007-08-16 |
AU2006325573A1 (en) | 2007-06-21 |
IL191761A0 (en) | 2008-12-29 |
CN101370793B (zh) | 2012-01-04 |
HK1121760A1 (en) | 2009-04-30 |
KR20080091139A (ko) | 2008-10-09 |
CA2631342A1 (en) | 2007-06-21 |
EP1968951B1 (en) | 2011-06-22 |
WO2007069978A1 (en) | 2007-06-21 |
CL2006003449A1 (es) | 2008-02-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ECSP088603A (es) | Nuevas n-(fluor-pirazinil)-fenilsulfonamidas como moduladores del receptor de quimioquina ccr4 | |
UY29058A1 (es) | Compuestos de isoindolona y su uso como potenciadores del receptor metabotropico de glutamato | |
UY29087A1 (es) | Derivados de adamantilo, composiciones farmaceuticas que los contienen, procesos para su preparacion y uso terapeutico | |
UY30976A1 (es) | Nuevos derivados de quinolina, composiciones farmaccuticas que los contienen, procesos de preparacion y aplicaciones. | |
UY29767A1 (es) | Derivados de benzotiazolonas, procesos para su preparación, composiciones farmacéuticas que los contienen y aplicaciones | |
UY29002A1 (es) | Nuevos derivados de hidantoína, procesos parasu preparación, composiciones farmacéuticas que los contienen y su uso en terapia | |
UY29732A1 (es) | Derivados de benzotiazolonas, procesos de preparación, composiciones y combinaciones que los contienen y aplicaciones | |
UY31524A1 (es) | Nuevos compuestos 010 | |
TW200801003A (en) | Novel compounds | |
UY28946A1 (es) | Compuestos de aril-y heteroaril-alquilanina que contienen pirazol, composiciones farmacéuticas que contienen los compuestos y nuevos productos químicos intermedios | |
UY32611A (es) | Compuestos de 1-cianoetilheterociclilcarboxamida sustituidos 750 | |
ECSP077271A (es) | Derivados de pirimidina | |
ECSP088329A (es) | Nuevos diazaespiroalcanos y su uso para el tratamiento de enfermedades mediadas por ccr8 | |
CL2008002768A1 (es) | Compuestos derivados de carboxiciclopropil-(bis-fenil-oxamidas); composicion farmaceutica que los contiene; procedimiento para la elaboracion de las composiciones y el uso de los compuestos en el tratamiento de diabetes y trastornos del sncentre otras enfermedades. | |
UY30481A1 (es) | Isoxazolinas sustituidas, composiciones farmaccuticas que contienen a las mismas, metodos de preparacion y usos. | |
TW200621262A (en) | New dihydropteridione derivatives, process for their manufacture and their use as medicament | |
GT200600518A (es) | Derivados de pirimidina | |
CL2012000925A1 (es) | Compuestos derivados de tetrahidrociclohepta[b]piridinilo, antagonista del receptor de cgrp; composicion farmaceutica que lo comprende; y su uso en el tratamiento de migraña, cefalea, diabetes, cancer, entre otras. | |
ECSP077259A (es) | Derivados de pirimidina | |
NI200700056A (es) | Nuevos derivados de sulfamidas de heteroaril benzo-fundido útiles como agentes anticonvulsivos | |
MX2010009022A (es) | Derivados 16 alfa, 17 alfa-acetal glucocorticoesteroideos y su uso. | |
UY30808A1 (es) | Derivados de benzotiazolonas, composiciones conteniéndolos y aplicaciones | |
AR047070A1 (es) | Derivados de difenilazetidona | |
UY31071A1 (es) | Derivados heterociclicos sustituidos y su uso farmaceutico y composiciones | |
UY29003A1 (es) | Nuevos derivados de hidantoína, procesos para su preparación, composiciones farmacéuticas que los contienen y su uso en terapia |